Data as of Oct 29
| 0.00 / 0.00%|
The 18 analysts offering 12-month price forecasts for Novozymes A/S have a median target of 45.39, with a high estimate of 51.82 and a low estimate of 37.10. The median estimate represents a +0.02% increase from the last price of 45.39.
The current consensus among 18 polled investment analysts is to Hold stock in Novozymes A/S. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.